Mid Atlantic Pemanente Medical Group

Mid Atlantic Pemanente Medical Group was paid $317.63M by Medicaid between Jan 2018 and Dec 2024, across 656 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 16% of everything it billed.

33Billing provider infoMID ATLANTIC PEMANENTE MEDICAL GROUP
ROCKVILLE, MD 20852

33aNPI1811062763assigned 11/22/2006

33bProvider typeHealth Maintenance Organization

28Total paid$317.63M

24GClaims10,112,770

24DCodes billed656

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Health Maintenance Organization providers in Maryland

Rank by total paid#1 of 8

Median peer was paid$2.92M

This provider vs. median109×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	141,305	$5.23M
2019	304,636	$8.14M
2020	1,316,493	$37.50M
2021	1,972,245	$64.56M
2022	2,089,255	$66.55M
2023	2,212,328	$69.92M
2024incomplete	2,076,508	$65.72M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	575,655	548,993	$50.80M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	7.1%	179,556	172,754	$22.63M
90670		3.5%	50,508	48,486	$11.22M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	3.2%	90,301	88,707	$10.13M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	3.1%	106,591	102,827	$9.99M
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	3.0%	13,246	12,850	$9.64M
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	2.9%	386,577	376,290	$9.07M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	2.7%	85,268	75,399	$8.57M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.1%	122,337	109,440	$6.81M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	1.9%	50,301	49,370	$6.17M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.9%	154,970	146,112	$5.90M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.9%	155,174	146,310	$5.89M

644 more codes

99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.8%	103,292	$5.67M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.7%	54,156	$5.28M
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	1.7%	35,053	$5.26M
77067	Screening mammography, bilateral, including computer-aided detection	1.6%	33,883	$5.06M
90472	Immunization administration, each additional vaccine (list separately)	1.5%	140,949	$4.67M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	1.5%	42,006	$4.64M
88305	Level IV - Surgical pathology, gross and microscopic examination	1.1%	27,542	$3.40M
90686		1.1%	166,617	$3.36M
36415	Collection of venous blood by venipuncture	<1%	686,676	$3.15M
84443	Thyroid stimulating hormone (TSH)	<1%	175,818	$2.96M
90677		<1%	10,063	$2.87M
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	118,654	$2.82M
V2020	Frames, purchases	<1%	59,058	$2.57M
80061	Lipid panel	<1%	191,598	$2.55M
99203	Doctor's office visit, new patient (routine)	<1%	21,843	$2.51M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	84,603	$2.48M
90723		<1%	36,387	$2.37M
99215	Doctor's office visit, returning patient (complex)	<1%	13,416	$2.29M
83036	Hemoglobin; glycosylated (A1C)	<1%	230,740	$2.23M
80051		<1%	309,147	$2.16M
99442		<1%	26,309	$2.13M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	10,673	$2.03M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	32,944	$1.94M
92015	Determination of refractive state	<1%	91,847	$1.75M
83721		<1%	165,307	$1.72M
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	<1%	32,855	$1.71M
85027		<1%	265,059	$1.70M
82565		<1%	333,368	$1.70M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	13,350	$1.63M
86803		<1%	115,668	$1.63M
71046	Radiologic examination, chest; 2 views	<1%	43,322	$1.58M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	11,941	$1.50M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	43,172	$1.49M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	187,455	$1.45M
86780		<1%	107,780	$1.43M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	24,536	$1.39M
86480		<1%	28,366	$1.39M
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	83,294	$1.30M
82947		<1%	330,283	$1.29M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	3,640	$1.25M
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	13,790	$1.24M
84520		<1%	315,924	$1.24M
80076		<1%	152,351	$1.23M
90648		<1%	55,309	$1.21M
86008		<1%	10,286	$1.12M
93000		<1%	68,873	$1.11M
88142		<1%	53,595	$1.08M
82274		<1%	64,842	$1.03M
76830	Ultrasound, transvaginal	<1%	7,688	$1.03M
81229		<1%	883	$930K
82728		<1%	68,442	$922K
92551		<1%	62,446	$861K
99204	Doctor's office visit, new patient (more involved)	<1%	4,696	$854K
90633		<1%	28,417	$844K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	9,926	$784K
90681		<1%	11,530	$765K
87506		<1%	2,831	$732K
82607		<1%	47,702	$714K
95800		<1%	4,666	$707K
87340		<1%	67,602	$690K
99205	Prolong outpt/office vis	<1%	2,890	$681K
99441		<1%	13,915	$653K
99460		<1%	8,032	$646K
83655		<1%	53,259	$643K
81025		<1%	76,404	$634K
99443		<1%	4,811	$603K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	16,831	$584K
82746		<1%	39,587	$577K
90480		<1%	9,473	$569K
87086	Culture, bacterial; quantitative colony count, urine	<1%	70,937	$568K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	3,698	$566K
83550		<1%	65,090	$563K
90656		<1%	25,681	$550K
99243		<1%	4,090	$538K
82570		<1%	99,009	$515K
87536		<1%	6,077	$500K
77063	Screening digital breast tomosynthesis, bilateral	<1%	8,618	$494K
82043		<1%	89,389	$490K
84153		<1%	24,084	$439K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	12,487	$436K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,555	$432K
99238	Hospital discharge day management, 30 minutes or less	<1%	6,494	$430K
83540		<1%	66,117	$425K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,017	$409K
80053	Comprehensive metabolic panel	<1%	39,136	$409K
84460		<1%	75,916	$400K
84702		<1%	28,029	$398K
0001A		<1%	8,265	$379K
86235		<1%	4,910	$367K
76642		<1%	3,613	$364K
0002A		<1%	7,382	$347K
98968		<1%	10,170	$344K
90734		<1%	1,807	$338K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,752	$337K
87081		<1%	49,131	$327K
84484		<1%	24,901	$322K
83880		<1%	8,236	$316K
81001		<1%	100,528	$316K
91320		<1%	2,283	$313K
87338		<1%	18,850	$309K
84403		<1%	11,825	$301K
83970		<1%	7,276	$298K
83690		<1%	42,887	$293K
86762		<1%	20,377	$274K
82105		<1%	15,829	$260K
88185		<1%	430	$253K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,079	$252K
99173		<1%	69,434	$244K
86706		<1%	22,782	$239K
81162		<1%	134	$237K
82670		<1%	8,367	$228K
70450	Computed tomography, head or brain; without contrast material	<1%	1,858	$221K
83001		<1%	12,143	$221K
84439		<1%	24,373	$218K
90834	Psychotherapy session, about 45 minutes	<1%	2,612	$213K
86787		<1%	16,991	$206K
86704		<1%	17,139	$205K
83020		<1%	16,215	$205K
72100		<1%	4,622	$204K
90716		<1%	2,360	$194K
92134		<1%	4,082	$186K
87517		<1%	4,520	$184K
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	<1%	2,320	$179K
87522	Neg quan hep c or qual rna	<1%	4,305	$177K
84146		<1%	9,279	$177K
80074		<1%	3,744	$176K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	311	$173K
90710		<1%	732	$173K
87186		<1%	18,515	$170K
97161		<1%	1,713	$169K
83735		<1%	24,768	$166K
86850		<1%	18,705	$164K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	1,267	$162K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	647	$160K
86705		<1%	13,737	$160K
80349		<1%	8,073	$158K
V2750	Anti-reflective coating, per lens	<1%	5,371	$158K
87901		<1%	622	$157K
87077		<1%	18,265	$155K
86038		<1%	12,903	$154K
76801		<1%	1,190	$153K
82784		<1%	11,824	$153K
88262		<1%	1,249	$153K
83002		<1%	8,338	$151K
98967		<1%	6,045	$151K
99245		<1%	586	$143K
80306		<1%	8,431	$142K
0004A		<1%	3,047	$142K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	11,443	$141K
76770		<1%	1,235	$138K
84450		<1%	26,795	$138K
80050	General health panel	<1%	13,699	$138K
99239	Hospital discharge day management, more than 30 minutes	<1%	1,417	$136K
86140		<1%	26,349	$136K
71271		<1%	842	$134K
83605		<1%	11,581	$134K
73630		<1%	3,384	$133K
96112		<1%	1,013	$133K
86003		<1%	7,225	$132K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	5,504	$130K
87040		<1%	8,118	$127K
88230		<1%	1,208	$126K
83516		<1%	10,258	$126K
90381		<1%	246	$125K
84270		<1%	5,857	$124K
84703		<1%	16,629	$123K
86361		<1%	4,654	$122K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	3,724	$120K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	883	$119K
82627		<1%	5,405	$118K
85610		<1%	27,517	$117K
82248		<1%	23,503	$115K
85379		<1%	12,482	$113K
87070		<1%	13,040	$113K
90707		<1%	2,253	$111K
80048	Basic metabolic panel (calcium, ionized)	<1%	13,165	$111K
84402		<1%	4,394	$110K
80348		<1%	4,193	$109K
73564		<1%	1,884	$105K
84425		<1%	5,483	$103K
92002		<1%	1,049	$98K
84207		<1%	3,523	$97K
87255		<1%	2,834	$95K
76818		<1%	619	$91K
72040		<1%	2,091	$91K
86710		<1%	6,433	$91K
99242		<1%	942	$90K
86160		<1%	3,922	$88K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	462	$88K
76536		<1%	714	$86K
77080		<1%	2,044	$86K
83498		<1%	3,129	$83K
86146		<1%	1,286	$83K
87653		<1%	2,397	$83K
83718		<1%	9,734	$81K
0124A		<1%	2,235	$81K
87493		<1%	2,216	$81K
81381		<1%	508	$80K
90651		<1%	5,076	$80K
87900		<1%	621	$80K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	565	$79K
86696		<1%	4,045	$79K
87563		<1%	2,002	$78K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	785	$76K
85652		<1%	27,585	$74K
82550		<1%	11,200	$74K
77066	Tomosynthesis, mammo	<1%	424	$74K
77065	Tomosynthesis, mammo	<1%	524	$71K
98966		<1%	5,185	$70K
67028	Intravitreal injection of a pharmacologic agent	<1%	525	$70K
84165		<1%	4,049	$69K
86225		<1%	5,058	$68K
97535	Self-care/home management training, each 15 minutes	<1%	1,921	$68K
92133		<1%	1,704	$68K
84445		<1%	1,620	$68K
86769		<1%	1,432	$67K
86376		<1%	4,641	$67K
80324		<1%	3,004	$67K
99462		<1%	1,846	$66K
95806		<1%	735	$65K
86735		<1%	4,959	$64K
86618		<1%	3,788	$64K
86765		<1%	5,107	$63K
92227		<1%	3,959	$63K
85730		<1%	10,787	$63K
99201		<1%	1,373	$61K
86147		<1%	1,367	$61K
80365		<1%	2,855	$60K
87625		<1%	1,485	$59K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	275	$59K
80354		<1%	2,985	$59K
83520		<1%	3,148	$59K
90647		<1%	1,921	$59K
81206		<1%	404	$59K
86200		<1%	4,576	$59K
80356		<1%	2,667	$58K
80359		<1%	2,836	$56K
20610		<1%	586	$56K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	250	$56K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	243	$56K
80373		<1%	2,704	$56K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	625	$55K
86695		<1%	4,034	$54K
82652		<1%	1,412	$53K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,915	$53K
84100		<1%	10,617	$52K
73610		<1%	1,233	$52K
84550		<1%	11,345	$51K
82247		<1%	10,464	$51K
82465		<1%	11,444	$50K
92567		<1%	3,007	$50K
86900		<1%	16,804	$49K
86901		<1%	16,800	$49K
90696		<1%	570	$48K
86800		<1%	3,078	$48K
74018		<1%	1,486	$48K
82951		<1%	3,742	$48K
86431		<1%	8,427	$47K
V2100	Sphere, single vision, plano to plus or minus 4.00, per lens	<1%	1,106	$47K
V2104	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens	<1%	979	$47K
86708		<1%	3,763	$47K
0071A		<1%	1,622	$46K
84630		<1%	4,153	$46K
82533		<1%	2,744	$46K
84480		<1%	3,239	$46K
80069		<1%	5,289	$45K
90474		<1%	3,326	$45K
87177		<1%	5,548	$44K
84156		<1%	12,186	$44K
85014		<1%	18,725	$44K
85018		<1%	18,609	$43K
91318		<1%	677	$43K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,012	$43K
80361		<1%	2,139	$42K
73110		<1%	931	$42K
86334		<1%	1,757	$42K
82310		<1%	7,479	$41K
82378		<1%	2,220	$41K
86304		<1%	1,976	$41K
83993		<1%	2,086	$40K
87210		<1%	7,068	$40K
V2784	Lens, polycarbonate or equal, any index, per lens	<1%	2,946	$40K
82157		<1%	1,335	$38K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	926	$38K
84144		<1%	1,908	$38K
0072A		<1%	1,338	$38K
86039		<1%	3,403	$37K
83883		<1%	1,448	$37K
90700		<1%	1,692	$36K
97803		<1%	666	$36K
84590		<1%	3,312	$36K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	92	$36K
83615		<1%	6,016	$36K
83921		<1%	1,741	$36K
87808		<1%	2,374	$35K
73221		<1%	153	$34K
88184		<1%	426	$34K
82977		<1%	4,772	$34K
91319		<1%	385	$34K
84132		<1%	7,144	$34K
73030		<1%	844	$33K
97802		<1%	491	$33K
70360		<1%	983	$33K
97162		<1%	345	$33K
85045		<1%	8,038	$32K
87905		<1%	2,621	$32K
80323		<1%	1,994	$31K
87205		<1%	7,102	$31K
83090		<1%	1,733	$31K
80197		<1%	2,242	$30K
87046		<1%	3,354	$30K
V2025	Deluxe frame	<1%	1,516	$30K
87045		<1%	3,214	$30K
87634		<1%	415	$28K
84481		<1%	1,770	$28K
82525		<1%	2,298	$28K
73130		<1%	635	$28K
82397		<1%	2,242	$28K
82024		<1%	723	$27K
90715		<1%	717	$27K
82040		<1%	5,371	$26K
86665		<1%	996	$26K
90791	Psychiatric diagnostic evaluation	<1%	148	$25K
88189		<1%	289	$25K
99241		<1%	493	$24K
V2107	Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens	<1%	551	$24K
93304		<1%	150	$24K
84252		<1%	1,401	$24K
83630		<1%	1,284	$24K
82150		<1%	3,474	$23K
84154		<1%	1,269	$23K
80346		<1%	1,013	$23K
81257		<1%	221	$22K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	236	$22K
82542		<1%	928	$21K
84182		<1%	178	$21K
81243		<1%	369	$21K
A9585	Injection, gadobutrol, 0.1 ml	<1%	726	$20K
11900		<1%	315	$20K
85240		<1%	1,183	$20K
86592		<1%	4,655	$20K
84466		<1%	1,583	$19K
84305		<1%	988	$19K
72070		<1%	518	$19K
86021		<1%	1,145	$18K
87449		<1%	1,500	$18K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	233	$18K
84075		<1%	3,371	$17K
84681		<1%	840	$17K
74183		<1%	44	$17K
86812		<1%	662	$17K
87807		<1%	1,251	$17K
83525		<1%	1,549	$17K
81403		<1%	105	$17K
82390		<1%	1,617	$17K
84155		<1%	4,456	$16K
87209		<1%	914	$16K
85008		<1%	4,641	$16K
81402		<1%	106	$16K
87109		<1%	1,027	$15K
93320		<1%	257	$15K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	459	$15K
99383		<1%	116	$15K
0064A		<1%	370	$15K
0054A		<1%	396	$15K
82103		<1%	1,108	$15K
82164		<1%	1,026	$15K
92310		<1%	1,159	$14K
90713		<1%	580	$14K
86382		<1%	465	$14K
85613		<1%	1,464	$14K
81241		<1%	195	$14K
82952		<1%	3,524	$14K
90750		<1%	117	$14K
85246		<1%	679	$13K
88342		<1%	95	$13K
87329		<1%	1,092	$13K
81219		<1%	108	$13K
0081A		<1%	471	$13K
87906		<1%	94	$13K
85245		<1%	648	$13K
82077		<1%	746	$13K
86308		<1%	2,442	$12K
80353		<1%	691	$12K
78815	Positron emission tomography (PET) for limited area imaging	<1%	12	$12K
84080		<1%	903	$12K
93325		<1%	440	$12K
82088		<1%	259	$12K
90837	Psychotherapy session, about an hour	<1%	86	$11K
87350		<1%	1,097	$11K
97164		<1%	157	$11K
86341		<1%	339	$11K
81270		<1%	133	$11K
87902		<1%	42	$11K
87147		<1%	1,685	$11K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	663	$11K
97165		<1%	107	$11K
86301		<1%	512	$11K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	726	$10K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	25	$10K
94729		<1%	166	$10K
86707		<1%	900	$10K
96381		<1%	523	$10K
86593		<1%	2,280	$10K
86317		<1%	96	$10K
87324		<1%	792	$9K
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,935	$9K
72197		<1%	26	$9K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	24	$9K
87641		<1%	259	$9K
83519		<1%	244	$9K
87341		<1%	847	$9K
84432		<1%	541	$9K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	27	$9K
92557		<1%	213	$8K
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	<1%	144	$8K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	14	$8K
87529		<1%	115	$8K
81002		<1%	2,443	$8K
88304		<1%	143	$8K
71275	Computed tomographic angiography, chest, with contrast material	<1%	26	$8K
93015		<1%	94	$8K
90792	Psychiatric diagnostic evaluation with medical services	<1%	37	$8K
83010		<1%	611	$8K
84295		<1%	1,717	$7K
92504		<1%	210	$7K
90839		<1%	47	$7K
87101		<1%	945	$7K
71045	Radiologic examination, chest; single view	<1%	248	$7K
70486		<1%	48	$7K
90691		<1%	119	$7K
88341		<1%	14	$7K
92550		<1%	313	$7K
90678		<1%	16	$7K
86644		<1%	520	$7K
88271		<1%	55	$7K
87106		<1%	627	$7K
92523		<1%	39	$6K
82330		<1%	529	$6K
V2744	Tint, photochromatic, per lens	<1%	853	$6K
72082		<1%	167	$6K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	464	$6K
V2520	Contact lens, hydrophilic, spherical, per lens	<1%	716	$6K
88312		<1%	28	$6K
93224		<1%	78	$6K
77061		<1%	43	$6K
86335		<1%	194	$6K
86141		<1%	444	$6K
99232	Hospital visit by a doctor, follow-up day	<1%	71	$6K
87149		<1%	85	$6K
88173		<1%	24	$6K
99385		<1%	37	$6K
90380		<1%	12	$5K
87593		<1%	61	$5K
77072		<1%	197	$5K
0154A		<1%	184	$5K
95816		<1%	13	$5K
89320		<1%	370	$5K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	27	$5K
73502		<1%	88	$5K
73080		<1%	127	$5K
94726		<1%	80	$5K
0082A		<1%	170	$5K
86663		<1%	360	$5K
86702		<1%	347	$5K
90632		<1%	103	$5K
83021		<1%	256	$4K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	117	$4K
00920		<1%	29	$4K
76885		<1%	31	$4K
81240		<1%	69	$4K
81050		<1%	897	$4K
87075		<1%	395	$4K
V2105	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens	<1%	82	$4K
V2108	Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens	<1%	100	$4K
94010		<1%	130	$4K
J7999	Compounded drug, not otherwise classified	<1%	212	$4K
82955		<1%	397	$4K
80178		<1%	570	$4K
80164		<1%	280	$4K
0052A		<1%	110	$4K
76820		<1%	60	$4K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	644	$4K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	53	$4K
86709		<1%	315	$3K
85303		<1%	261	$3K
72141		<1%	14	$3K
71250		<1%	24	$3K
85660		<1%	627	$3K
84244		<1%	156	$3K
88188		<1%	54	$3K
54150		<1%	19	$3K
82656		<1%	279	$3K
94060		<1%	69	$3K
0051A		<1%	97	$3K
84436		<1%	452	$3K
86617		<1%	99	$3K
86255		<1%	105	$3K
86645		<1%	217	$3K
86701		<1%	338	$3K
81279		<1%	16	$3K
81339		<1%	16	$3K
73140		<1%	64	$3K
85306		<1%	184	$3K
82085		<1%	284	$3K
99417	Prolong home eval add 15m	<1%	41	$3K
99223	Prolong inpt eval add15 m	<1%	14	$3K
87581		<1%	71	$2K
86300		<1%	140	$2K
85300		<1%	218	$2K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	36	$2K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	49	$2K
64615		<1%	13	$2K
80047		<1%	197	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	114	$2K
93971		<1%	17	$2K
99386		<1%	12	$2K
0074A		<1%	69	$2K
0011A		<1%	49	$2K
0111A		<1%	70	$2K
86162		<1%	104	$2K
90746		<1%	42	$2K
97799		<1%	97	$2K
87799		<1%	57	$2K
99384		<1%	12	$2K
91321		<1%	12	$2K
85004		<1%	261	$2K
73521		<1%	37	$2K
76882		<1%	28	$1K
86340		<1%	124	$1K
81207		<1%	13	$1K
86777		<1%	117	$1K
89051		<1%	240	$1K
90674		<1%	58	$1K
96375	Therapeutic injection; each additional sequential IV push	<1%	52	$1K
77062		<1%	12	$1K
90685		<1%	62	$1K
95125		<1%	211	$1K
84478		<1%	224	$1K
99222	Initial hospital care, per day, moderate complexity	<1%	13	$1K
83521		<1%	97	$1K
59025	Fetal non-stress test	<1%	22	$1K
99221		<1%	13	$1K
92587		<1%	43	$969.92
92570		<1%	25	$952.23
86355		<1%	25	$943.25
82668		<1%	56	$892.21
97750		<1%	25	$880.10
0003A		<1%	19	$847.80
96900		<1%	37	$806.99
81256		<1%	12	$784.32
89240		<1%	535	$763.35
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	781	$757.61
36416		<1%	746	$749.57
88300		<1%	38	$738.53
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	19	$706.18
V2204	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens	<1%	14	$704.00
73562		<1%	13	$703.57
93296		<1%	28	$703.00
87497		<1%	17	$678.03
92025		<1%	15	$638.55
97014		<1%	49	$627.44
90717		<1%	15	$611.62
87535		<1%	18	$596.53
86870		<1%	110	$595.50
82104		<1%	49	$589.26
82610		<1%	33	$571.56
85305		<1%	52	$568.89
86325		<1%	13	$567.18
86360		<1%	12	$563.76
86922		<1%	61	$562.98
V2111	Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens	<1%	14	$560.00
92579		<1%	14	$555.51
86920		<1%	60	$538.90
92552		<1%	12	$523.32
84300		<1%	100	$495.88
80230		<1%	14	$493.68
82140		<1%	33	$480.81
83835		<1%	28	$474.32
73560		<1%	13	$471.67
87486		<1%	13	$456.17
92250		<1%	14	$455.89
86359		<1%	12	$452.76
85049		<1%	102	$452.48
85384		<1%	62	$425.82
86880		<1%	55	$411.48
82785		<1%	24	$395.04
0112A		<1%	14	$392.42
73090		<1%	13	$392.31
92555		<1%	12	$385.20
80177		<1%	29	$371.00
V2745	Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens	<1%	26	$365.22
0083A		<1%	12	$336.36
86664		<1%	27	$330.55
86750		<1%	26	$315.01
82365		<1%	27	$305.73
83789		<1%	12	$289.32
82945		<1%	69	$275.10
87207		<1%	41	$255.63
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	14	$231.42
82530		<1%	14	$227.23
87184		<1%	13	$221.26
86336		<1%	13	$202.67
87015		<1%	26	$196.32
85670		<1%	39	$188.82
V2783	Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens	<1%	115	$176.50
80183		<1%	13	$172.25
86682		<1%	12	$169.13
83825		<1%	12	$133.02
84157		<1%	30	$132.00
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	34	$82.80
J2270	Injection, morphine sulfate, up to 10 mg	<1%	13	$75.82
83935		<1%	12	$67.11
J3490	Unclassified drugs	<1%	41	$58.30
84133		<1%	12	$56.76
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	39	$42.83
81003		<1%	13	$36.01
V2799	Vision item or service, miscellaneous	<1%	964	$30.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	125	$21.61
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	42	$14.58
80358		<1%	20	$8.78
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	12	$3.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	13	$1.82
91307		0%	6,507	$0.00
99024		0%	853	$0.00
91305		0%	1,635	$0.00
V2781	Progressive lens, per lens	0%	633	$0.00
91301		0%	52	$0.00
0500F		0%	52	$0.00
91306		0%	376	$0.00
91315		0%	236	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	20	$0.00
91303		0%	36	$0.00
0503F		0%	12	$0.00
97804		0%	12	$0.00
91317		0%	40	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	32,557	$0.00
0502F		0%	45,817	$0.00
91300		0%	28,678	$0.00
91312		0%	2,448	$0.00
91308		0%	2,397	$0.00
91311		0%	207	$0.00
99446		0%	24	$0.00
0034A		0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTAYLOR, SHARON (VICE PRESIDENT OF FINANCE)